Skip to main content
OpenTrials

Clinical trial condition

Histiocytic Disorders, Malignant

Explore clinical trials studying Histiocytic Disorders, Malignant. Study availability and eligibility vary by location and protocol.

260 public trials 43 recruiting studies
Refine in advanced search Browse all conditions

Histiocytic Disorders, Malignant trial results

Recruiting

Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy

NCT05377307

Conditions
Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3A, +16 more
Locations
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung, Taiwan
  • National Taiwan University Hospital Taipei, Taiwan
  • Taipei Veterans General Hospital Taipei, Taiwan
  • Chi Mei Medical Center Tainan, Taiwan
View Trial Details
Recruiting

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

NCT05476770

Conditions
ALL, AML, Acute Undifferentiated Leukemia, +30 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Orange County Orange, California, United States
  • UCSF School of Medicine San Francisco, California, United States
  • Children's Hospital Colorado Denver, Colorado, United States
View all 31 locations
View Trial Details
Recruiting

Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL

NCT05641428

Conditions
DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
Locations
  • NL-Amsterdam-AMC Amsterdam, Netherlands
  • NL-Groningen-UMCG Groningen, Netherlands
  • NL-Leiden-LUMC Leiden, Netherlands
  • NL-Maastricht-MUMC Maastricht, Netherlands
View Trial Details

Related conditions